News Merck Wins First FDA Approval of an Oral PCSK9 Inhibitor with Cholesterol Pill Lipfendra pharminent July 16, 2026
News J&J Beats Q2 Estimates, Raises Full-Year Guidance on Innovative Medicine Strength pharminent July 15, 2026
Manufacturing J&J Streamlines Pharma Supply Chain Amid $55B US Manufacturing Push pharminent July 15, 2026
News Biogen’s Tau-Targeting Alzheimer’s Data Show Promise — and Raise Questions pharminent July 14, 2026
Clinical Data Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugs pharminent July 14, 2026
M&A / Deals AstraZeneca takes another China trip, picking Dizal’s lung cancer drug for up to $1.5B pharminent July 14, 2026
M&A / Deals Novartis and Chai Discovery collaborate on antibody identification pharminent July 14, 2026
Manufacturing Cellares and Sonoma partner to automate cell therapy manufacturing pharminent July 14, 2026
Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
Manufacturing “Hub-and-spoke” drug manufacturing set to benefit from new FDA rule pharminent July 13, 2026
News Roche Scraps Two Ionis-Partnered Huntington’s Studies After Tominersen Failure pharminent July 10, 2026
Pipeline AAIC 2026: Tau-targeted Alzheimer’s treatments heat up while amyloid therapies persist pharminent July 10, 2026
Clinical Data GSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China pharminent July 10, 2026
M&A / Deals Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar pharminent July 10, 2026
Clinical Data AstraZeneca, Ionis drug fails big heart disease study in major setback pharminent July 9, 2026
Regulatory FDA freezes CRL trove as ‘radical transparency’ push hits speedbump pharminent July 9, 2026
News Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens Partnership With GSK pharminent July 8, 2026
M&A / Deals AstraZeneca bets up to $1.9B in respiratory disease collab with Sino Biopharmaceutical pharminent July 8, 2026
M&A / Deals Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant pharminent July 8, 2026
